Form 8-K - Current report:
SEC Accession No. 0000886163-18-000052
Filing Date
2018-04-13
Accepted
2018-04-12 20:50:29
Documents
1
Period of Report
2018-04-13
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K roivantcvr8k41318.htm 8-K 19711
  Complete submission text file 0000886163-18-000052.txt   20927
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 18753010
SIC: 2834 Pharmaceutical Preparations